EHA2026 sponsorship opportunities
By sponsoring the EHA Congress, you’ll gain brand exposure to over 17,000 influential and hard-to-reach hematology experts, researchers, and industry professionals—from across Europe and beyond.
We offer a broad range of options to meet a wide range of sponsorship budgets.
EHA2026 Congress: Connect. Enrich. Progress.
The EHA Congress is the biggest and most important hematology Congress in the European calendar. This year’s Congress will take place in Stockholm, Sweden, from June 11–14, 2026.
- Dozens of renowned speakers and presentations
- Exhibition space with stands hosted by industry leaders and our non-profit partners
- Poster sessions where the community meets abstract authors, gains valuable insights, and expands their networks
EHA2026 Congress keeps the community at the forefront of the field, creates new connections, sparks innovation, and accelerates progress:
You can reach an even bigger audience through the Congress platform—our online space for livestreaming and on-demand content.
The platform is a way for you to tap into a large audience that spends more time with content—before, during, and after our in-person Congress. It’s available as both a platform and an app.
- Unrivalled brand exposure through rich physical and digital touch-points—before, during, and after the in-person Congress.
- Networking opportunities with the most influential figures in the hematology community.
- Insights into emerging trends and critical market insights from those on the forefront of hematology.
Additionally, partnership helps you to:
- Align with public health goals
- Support education and professional development
- Make an impactful contribution to scientific progress
EHA welcomes and values long-term partnerships with our sponsors.
Check out the sponsorship program or send an email to [email protected] to find out more.
Compliance
EHA2026 Congress has received full compliance clearance. For further information, please refer to Ethical MedTech.
Beyond Congress
Although EHA Congress is our flagship event, partnership with EHA offers a myriad of other sponsorship opportunities, including:
- The EHA Unplugged podcast
- The EHA Campus education series
- The EHA Master Class advanced online training program
- Access to Specialized Working Group (SWG) meetings
- A broad range of research meetings and conferences
- Access to the HemaSphere publication
Partner for progress with EHA
EHA is dedicated to transforming the landscape of hematology through our commitment to innovation, collaboration, and global connectivity.
Over the past three years, we’ve positioned ourselves as a future-ready organization, addressing the evolving needs of the hematology community in Europe, and beyond.
Our mission is to transcend physical and intellectual borders by fostering a robust, worldwide network of professionals. Our network is not just a professional association; it’s a community that nurtures growth, mentorship, and innovation in a manner that transcends geographical and intellectual borders.
We call it Borderless Hematology. And we’d love you to join us on this journey.
A special thank you to our sponsors
- Johnson & Johnson
- Abbvie Inc.
- Bristol Myers Squibb
- Sanofi
- Novartis Pharma AG
- Gilead & Kite
- AstraZeneca
- Roche
- GSK
- BeOne Medicines
- Eli Lilly and Company
- Pfizer, Inc.
- Takeda Pharmaceuticals International Co.
- Incyte
- Vertex Pharmaceuticals, Inc.
- Menarini Stemline
- Genmab
- Astellas
- Regeneron Pharmaceuticals, Inc.
- Otsuka Pharmaceutical Europe Ltd.
- SERVIER
- Amgen, Inc.
- Jazz Pharmaceuticals
- Swedish Orphan Biovitrum (Sobi)
- Agios Pharmaceuticals
- Daiichi Sankyo, Inc.
- MSD
- Grifols
- Octapharma
- Oncopeptides AB
- Geron Corporation
- Nurix Therapeutics, Inc
- Secura Bio, Inc.
- Medscape Global Oncology
- Novo Nordisk Healthcare AG
- Blueprint Medicines, a Sanofi company
- LABORATOIRES Pierre Fabre
- Miltenyi Biomedicine GmbH
- Med Learning Group
- Thermo Fisher Scientific
- SERB Pharmaceuticals
- Mission Bio
- The Video Journal of Hematology and Hematological Oncology (VJHemOnc)
- Adaptive Biotechnologies
- Binding Site, part of Thermo Fisher Scientific
- Cogent Biosciences, Inc.
- Society of Hematologic Oncology
- National Comprehensive Cancer Network (NCCN)
- Silence Therapeutics
- MDS Foundation
- Sumitomo Pharma America, Inc.
- Ryvu Therapeutics
- International Academy for Clinical Hematology
- AXON
- Enliven Therapeutics, Inc.
- Foundation Medicine, Inc.
- AOP Health
- Sysmex Europe SE
- Natera
- International Myeloma Society
- Kartos Therapeutics, Inc.
- Decera Clinical Education
- Fulcrum Therapeutics, Inc.
- Kyowa Kirin, Inc.
- Parexel
- Italian Society of Hematology – Studio ER Congressi
- The American Society of Hematology
- Japanese Society of Hematology
- Turkish Society of Hematology
- Brazilian Association of Hematology, Hemotherapy and Cell Therapy – ABHH
- APLUSA
- Ipsen
- Invivoscribe
- Haematologica Journal
- PSI CRO
- Ascentage Pharma Group
- American Association for Cancer Research (AACR)
- Vaniam Group
- Dendrite Clinical Systems Ltd
- Noul Co., Ltd.
- Terns Pharmaceuticals
- Recordati Rare Diseases
- Scientific Education Support (SES) Ltd.
- Rarity Bioscience AB
- Cellecta, Inc.
- Mundipharma
- Genomic Testing Cooperative
- Enable Injections, Inc.
- European School of Haematology (ESH)
- EBMT
- GenQA
- Pixelgen Technologies
- KORU Medical Systems
- BD Biosciences
- Avanzanite Bioscience B.V.
- Disc Medicine, Inc.
- Devyser
- BostonGene
- Bio‑Techne Spatial
- Syndax Pharmaceuticals, Inc.
- medac GmbH
- Arog Pharmaceuticals
- Moleculin Biotech, Inc.
- Telios Pharma, Inc.
- Sqilline Health
- Azurity Pharmaceuticals
- Cancilico GmbH
- Altum Sequencing
- LegendLegend Biotech USA Biotech
- 300K Solutions
- X4 Pharmaceuticals, Inc.
Get in touch
EHA contact
EHA Executive Office
Tel: +31 (0)70 302 0099
Email: [email protected]
INTERPLAN contact
INTERPLAN Congress, Meeting & Event Management AG
Tel: +49 (0)40 32 50 92 43
Email: [email protected]